4DMedical (ASX:4DX) said its operating revenue for the fiscal first half came in at AU$2.9 million, with its underlying software-as-a-service revenue up 31% year-over-year, according to a Friday Australian bourse filing.
It expanded its existing distribution agreement with Koninklijke Philips, under which Philips will distribute CT:VQ, the firm's computed tomography-based ventilation-perfusion imaging technology, to healthcare systems across the US and Canada on full commercial terms.
The agreement includes a mechanism wherein Philips underwrites the minimum order commitment of around AU$15 million in customer orders over 2026 and 2027.
Its shares jumped 6% in recent trading on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.